Rwanda Biomedical Centre

What Rwanda Biomedical Centre does

Rwanda Biomedical Centre (RBC) is the Government of Rwanda's central health implementation agency, formed in 2011 through the consolidation of 14 predecessor health institutions under the Ministry of Health. Headquartered in Kigali, the agency operates a nationwide integrated health services platform spanning all 30 districts of Rwanda and reaching 515 health centers, 100 health posts, district and referral hospitals, and a network of 60,000 trained community health workers. RBC delivers infectious disease diagnosis and treatment, maternal and child health, blood transfusion, mental health, non-communicable disease management, and national reference laboratory services for the Rwandan population.

The agency's core technology stack centers on an integrated One Health surveillance architecture: the e-IDSR (electronic Integrated Disease Surveillance and Response) system captures data across human, animal, and environmental health sectors; the IMPURUZA platform supports community-level event-based surveillance; the National Health Intelligence Center (NHIC) consolidates dashboards and outbreak monitoring; and Laboratory Information Systems (LIS) support diagnostic workflows. Recent additions include an AI Screening Tool for Mpox and priority diseases deployed at 12 Points of Entry. The SPPROHRW project (Strengthening Pandemic Prevention and Response Through One Health Approach, 2024-2027) is the flagship modernization initiative, funded by a US$24.9 million Pandemic Fund grant with over US$160 million in partner co-investment and co-financing.

RBC's operating model is non-commercial: services are delivered free at point of use through the public healthcare system, with funding sourced from the Rwandan government health budget and a dense ecosystem of multilateral and bilateral donors including WHO, UNICEF, FAO, CHAI, the Pandemic Fund, US CDC, PEPFAR, Gavi, the Global Fund, AIIB, Africa CDC, and the World Bank. The agency is governed by a Board of Directors appointed by Cabinet Decision (since 2016), led by Director General Prof. Claude Mambo Muvunyi, and operates as a wholly government-owned state entity with no private equity, venture, or public shareholders.

Name

Rwanda Biomedical Centre

Legal name

Rwanda Biomedical Centre

Website

https://rbc.gov.rw

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Rwanda Biomedical Centre is Rwanda's central government health implementation agency, formed in 2011 by merging 14 health institutions. It delivers integrated One Health surveillance, diagnostics, and clinical programs across all 30 districts to the Rwandan population through public health facilities and 60,000 community health workers.

Ownership category

akta.pro rank

Product category

Public Health Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Scientific Research and Development Services (5417)

SIC

Services-Medical Laboratories (8071), Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Public Health Laboratories & Diagnostic Oversight (BPAIAJAF)

akta.pro secondary industries

Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM), Public–Private Partnerships (PPPs) for Global Health (HLAJAOAD), Community Health, Health Promotion & Behavior Change (SBCC) (BPADAIAL)

Keywords

• Public health services
• Biomedical research
• Epidemic surveillance
• Health laboratory diagnostics
• Immunization programs

Headquarters

HQ city

Kigali

HQ country

Rwanda

HQ region

Africa

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Others

Revenue model

1. Government Health Budget: Core operational funding from the Rwandan Government Ministry of Health budget, supporting all national health programs, disease prevention initiatives, diagnostic services, and health infrastructure maintenance.
2. International Development Partner Funding: Funding from international health organizations including Pandemic Fund ($24.9M grant), WHO, UNICEF, Clinton Health Access Initiative, FAO, World Bank, and various bilateral donors supporting specific health programs and capacity building initiatives.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

Core offering

Rwanda Biomedical Centre (RBC) is a government health implementation agency under Rwanda's Ministry of Health that coordinates public health services, disease surveillance, diagnostics, and laboratory services nationwide. It manages immunization programs, epidemic preparedness and response, and operates digital health platforms such as e-IDSR, IMPURUZA, and the National Health Insurance Coverage (NHIC) platform. RBC was formed in 2011 through the merger of 14 health institutions and oversees a network of 521 health facilities supported by approximately 60,000 community health workers.

Product overview

Rwanda Biomedical Centre operates as a national health implementation agency offering a portfolio of digital health platforms and surveillance systems rather than a traditional software product suite. The core offerings include the e-IDSR (electronic Integrated Disease Surveillance and Response) system—a nationwide digital platform launched November 3, 2025, for integrated monitoring across human, animal, and wildlife health sectors; the IMPURUZA community event-based surveillance platform enabling frontline health workers to report health events in real-time; and the National Health Intelligence Center (NHIC) serving as a centralized digital hub for health data integration and analytics. The SPPROHRW initiative represents a major three-year project (2024-2027) focused on pandemic prevention through enhanced surveillance, laboratory systems strengthening, and workforce development. Supporting infrastructure includes National Reference Laboratory services and AI-powered screening tools deployed at Points of Entry. These offerings are primarily government-operated platforms serving Rwanda's public health system rather than commercial software products.

Differentiator

Problem solved

Functional benefit

Products and services

• Disease Surveillance and Epidemic Response National surveillance, detection, and coordinated response to epidemic-prone diseases and public health events, using the electronic Integrated Disease Surveillance and Response (e-IDSR) platform to aggregate data from health facilities across Rwanda.
• Laboratory and Diagnostic Services National reference laboratory diagnostic testing and a coordinated specimen referral and transportation system serving health facilities across Rwanda.
• National Immunization Program Planning, coordination, and delivery of routine and campaign immunization services across Rwanda, supported by cold chain logistics and vaccine delivery infrastructure.
• IMPURUZA Digital Health Platform Digital health information platform used by Rwanda Biomedical Centre and partner institutions to support health service delivery, data management, and reporting.
• National Health Insurance Coverage (NHIC) Platform Digital platform supporting health insurance coverage and access for the population of Rwanda.

Quantifiable outcome

• e-IDSR system operational across all 521 health facilities nationwide
• +3 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

14 partnerships are on record, tiered core and minor.

• Clinton Health Access Initiative (CHAI)coreStrategic or Co-development PartnerKey technical and financial partner in developing and operationalizing the e-IDSR system for animal health and wildlife sectors. Provided support for One Health surveillance platform development.
• World Health Organization (WHO)coreStrategic or Co-development PartnerLong-standing technical partner supporting IHR compliance, Joint External Evaluations, training, equipment provision, and global health security alignment.
• Food and Agriculture Organization (FAO)coreImplementation/ SI/ Consulting PartnerImplementing entity for SPPROHRW, providing expertise in animal health. Supports veterinary surveillance, laboratory strengthening, and One Health coordination.
• UNICEFcoreImplementation/ SI/ Consulting PartnerImplementing entity providing expertise in water, sanitation, hygiene and community-level activities. Supplied 615+ tablets for surveillance.
• Rwanda Agriculture and Animal Resources Development Board (RAB)coreImplementation/ SI/ Consulting PartnerKey national partner for animal health surveillance, veterinary laboratory services, and One Health implementation in animal sector.
• Rwanda Development Board (RDB)coreImplementation/ SI/ Consulting PartnerPartner for wildlife health surveillance and environmental aspects of One Health approach.
• University of RwandacoreImplementation/ SI/ Consulting PartnerAcademic partner for research, workforce development, curriculum development for veterinary and public health programs.
• Partners In Health (PIH)minorStrategic or Co-development PartnerInternational nonprofit providing technical support for healthcare delivery and disease control programs.
• Africa CDCcoreStrategic or Co-development PartnerContinental health organization supporting disease surveillance, outbreak response coordination, and capacity building.
• US Centers for Disease Control and Prevention (US CDC)minorStrategic or Co-development PartnerTechnical partner supporting epidemiology training, surveillance systems, and public health capacity building.
• JhpiegominorImplementation/ SI/ Consulting PartnerInternational health organization supporting training for Marburg Virus Disease surveillance and outbreak response.
• AMR Policy AcceleratorcoreStrategic or Co-development PartnerPartnership for National Action Plan on Antimicrobial Resistance (AMR) development, providing Smart Choice Process methodology for strategic prioritization.
• ReAct AfricaminorStrategic or Co-development PartnerGlobal network working on antimicrobial resistance awareness and policy development support.
• Greater Virunga Transboundary Collaboration (GVTC)coreStrategic or Co-development PartnerRegional partnership for One Health coordination across Rwanda, Uganda, and DRC in the Greater Virunga Landscape.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Kenya Medical Research Institute (KEMRI): Kenya's national medical research institute with similar functions in disease surveillance, reference laboratory services, and public health research. Comparable scope and donor-base composition, with one of the largest biomedical research footprints in East Africa.
• Tanzania National Institute for Medical Research (NIMR): Tanzania's national medical research body with comparable mandate in disease surveillance, laboratory research, and public health program support. Operates at similar institutional scale and serves as a realistic benchmark within the East African Community.
• Ethiopian Public Health Institute (EPHI): Ethiopia's central public health reference institute conducting surveillance, laboratory diagnostics, and research. Comparable national-government agency operating a One-Health-adjacent mandate with similar donor-dependency profile (WHO, USAID, Pandemic Fund).
• South African National Institute for Communicable Diseases (NICD): South Africa's national reference laboratory and surveillance body. Comparable as a more advanced, higher-resource national public health institute that performs similar functions — laboratory reference testing, outbreak response, and disease surveillance — providing a roadmap for institutional scale.
• Pasteur Institute of Dakar: Senegal-based biomedical research institute with a reference laboratory and vaccine production capacity. Comparable scope in producing diagnostics, training researchers, and supporting regional outbreak response across West/Central Africa.
• Nigeria Centre for Disease Control (NCDC): Nigeria's national public health institute responsible for disease surveillance, outbreak response, and reference laboratory services. Comparable as a peer national public-health agency operating e-IDSR-equivalent systems and IHR compliance work in a larger, more complex federal context.
• Uganda Virus Research Institute (UVRI): A national biomedical research and surveillance institute in a neighboring East African country. Comparable as a near-clone of RBC's reference-laboratory and outbreak-response mandate, with similar zoonotic-disease portfolio (Ebola, Marburg, RVF) and overlap in the Greater Virunga Transboundary Collaboration.

Others

• Partners In Health (PIH): An international nonprofit providing technical support for healthcare delivery and disease control programs in low-resource settings. Listed as an RBC strategic partner; comparable as a delivery-side implementer rather than a peer institute, but adjacent in mandate and donor ecosystem.
• Zenysis Technologies: A health-data integration platform that partners with national health systems in low-resource settings. Listed as a partner of RBC on its website; comparable as an enabling technology provider for integrated health surveillance rather than a direct competitor.

Broad incumbents

• Africa CDC: The continental public-health agency of the African Union. Comparable as a higher-tier counterpart to RBC: both are public health implementation bodies operating disease surveillance, outbreak response, and laboratory coordination, but Africa CDC operates at the continental level rather than a single country.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/RBCRwanda
• YouTubeyoutube.com/channel/UCYtRdeEh1ODvBuZjSZWV2XQ
• Facebookfacebook.com/rwandahealth
• LinkedInlinkedin.com/company/rwanda-biomedical-centre
• TikToktiktok.com/@rwanda.health/video/7400478065198910725?_t=8ogMq80G2lR&_r=1

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rwanda Biomedical Centre